JUNTENDO EDUCATIONAL FOUNDATION has a total of 17 patent applications. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are DIATECH KOREA CO LTD, TOLERO PHARMACEUTICALS INC and LANKENAU INST MEDICAL RES.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 11 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | United States | 2 | |
#4 | Canada | 1 | |
#5 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Foods and drinks | |
#6 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Heterocyclic compounds | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes | |
#7 | Enzymes | |
#8 | Peptides | |
#9 | Electrotherapy | |
#10 | Measuring nuclear radiation |
# | Name | Total Patents |
---|---|---|
#1 | Hiramatsu Keiichi | 5 |
#2 | Baba Tadashi | 5 |
#3 | Morimoto Yuh | 5 |
#4 | Oomiya Hiroko | 4 |
#5 | Ito Masayoshi | 4 |
#6 | Kawaji Hideya | 4 |
#7 | Hayashizaki Yoshihide | 4 |
#8 | Miyagi Yohei | 2 |
#9 | Hira Kayako | 2 |
#10 | Hayakawa Isao | 2 |
Publication | Filing date | Title |
---|---|---|
WO2015174539A1 | Method for detecting cells | |
WO2015115544A1 | Evaluation method for risk of metastasis or recurrence of colon cancer | |
WO2015105190A1 | Method for assessing lymph node metastatic potential of endometrial cancer | |
WO2015105191A1 | Method for assessing lymphadenopathy lesions | |
WO2014178427A1 | Method for controlling expression of semaphorin 3a | |
WO2014171527A1 | Novel compound with antibacterial activity | |
WO2011093183A1 | Method of measuring two-dimensional distribution of radiological dose using 3d phantom | |
EP1908467A1 | Agent for treating herpesvirus-derived pain |